VEGFA and psoriasis: Despite the limited number of skin biopsies and donors that were available for study, our preclinical data encourage one to systematically explore clinically whether blocking VEGF‐A is an effective adjunct management strategy for downregulating psoriasis‐associated pathological angiogenesis.